Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 22Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasm Metastasis 2Metastatic Hormone-sensitive Prostate Cancer 2Non-metastatic, Hormone naïve Prostate Cancer 1Metastatic Hormone Sensitive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Hormone Sensitive Prostate Cancer 1Adenocarcinoma of the Prostate 1

Interventions

enzalutamide 2Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Metastatic Hormone Sensitive Prostate Cancer × Androgen Antagonists × Clear all
NCT04076059 2026-04-17

China ARCHES

Astellas Pharma Inc

Phase 3 Active not recruiting
180 enrolled 24 charts
Genitourinary

Metastatic Hormone Sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡